GL1X · GenesisL1 explorer

Research workbench

Epstein barr virus major envelope glycoprotein

Analyse Epstein barr virus major envelope glycoprotein in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2H6O
Type
protein
Length
440 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Major outer envelope glycoprotein GP350
UniProt
Q9QP87
Ligands
MAN, NAG, BMA, GAL, NDG, FUC
Pockets
4 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMajor outer envelope glycoprotein GP350protein4403% helix, 38% strandQ9QP87

Ligands and binding sites

  • MAN · alpha-D-mannopyranose · sugar · 57 copies · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 27 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · 6 copies · chains A
  • GAL · beta-D-galactopyranose · sugar · 6 copies
  • NDG · 2-acetamido-2-deoxy-alpha-D-glucopyranose · sugar · 3 copies · chains A
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.490.8718empty
21180.420.7727empty
3650.360.7815empty
4630.320.7618empty

Modifications

Observed in the structure: 10 glycan, 5 disulfide (N-glycosylation, disulfide).

Compared structures

  • 2H6O · Epstein Barr Virus Major Envelope Glycoprotein · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.